Black-Market Weight Loss Drugs: What CBS News Found and Why It Matters

A recent CBS News investigation raises serious questions about unregulated weight-loss injections, experimental peptides, and the importance of proper medical oversight.

The growing popularity of weight-loss medications has created new options for patients seeking medical help with obesity and related health concerns. But it has also attracted sellers offering experimental or unregulated injectable products online, sometimes without meaningful medical evaluation.

In an investigation published on October 21, 2026, CBS News purchased products marketed as retatrutide, an experimental weight-loss drug still being studied in clinical trials.

The journalists wanted to answer a simple but important question: What are consumers actually receiving when they buy these products?

The results highlight why patients should be cautious about black-market weight-loss drugs and why a legitimate clinical evaluation, appropriate prescribing, and verified medication sourcing matter.

What Did the CBS News Investigation Find?

CBS News correspondent Adam Yamaguchi purchased products sold as retatrutide from multiple sources.

Two purchases were made online. According to CBS, one seller had promised a health evaluation, but the medication arrived without the reporter speaking to a healthcare professional. Another seller indicated that a doctor would review an intake form, yet the product was delivered without a consultation.

A third purchase came from a convenience store in Brooklyn, where a vial labeled as retatrutide was sold for $90. The product was marked for research use rather than human consumption.

CBS then arranged laboratory testing to investigate what the purchased products contained.

University of Iowa research scientist Jason Galpin found that the two online samples were consistent with a basic reference standard he had developed for retatrutide. However, that limited analysis did not establish that the products were sterile, clinically safe, or equivalent to the medication used in controlled clinical trials.

The convenience-store sample produced a more concerning result.

According to CBS, the sample did not appear to contain a peptide. Testing instead identified phenylacetic acid, and further analysis found 13 bacterial colonies in the sample.

These findings do not mean every product marketed as retatrutide is contaminated. They do demonstrate why patients cannot assume that an injectable drug contains what its label claims.

Source: CBS News — Original Investigation

Watch the CBS News Investigation

CBS News: We Bought What Was Sold as an Experimental Weight Loss Drug. Then We Tested It.

Watch the CBS News video on YouTube

The video accompanies CBS’s reporting on unregulated weight-loss medications and laboratory testing. Readers can review the original investigation for additional details about the samples, testing methods, and expert commentary.

What Is Retatrutide, and Is It FDA-Approved?

Retatrutide is an experimental medication being studied for potential weight-management and metabolic applications. It acts on multiple hormone receptors involved in metabolic regulation.

As of October 22, 2026, retatrutide has not received FDA approval for weight loss or any other medical condition.

That distinction is essential.

A medication showing promise in clinical trials is not automatically approved for routine prescribing or commercial distribution. Clinical trials are designed to evaluate questions about effectiveness, side effects, appropriate dosing, and overall safety.

The FDA has also stated that retatrutide cannot be used in compounding under federal law.

Patients should be particularly cautious when websites advertise retatrutide as a readily available prescription treatment or offer vials labeled “research use only” for personal injection.

A seller’s description of a product as experimental, pharmaceutical-grade, or laboratory-tested does not replace FDA authorization or clinical safeguards.

Source: FDA — Concerns With Unapproved GLP-1 Drugs

Five Risks of Buying Unregulated Weight-Loss Injections

1. The product may not contain the advertised ingredient

The CBS investigation demonstrated this concern directly: one vial marketed as retatrutide did not appear to contain the advertised peptide.

Counterfeit or unregulated products may contain the wrong ingredient, an inaccurate quantity of an ingredient, or substances that are not disclosed on the label.

When a patient cannot verify a product’s identity or source, its effects may be unpredictable.

2. Injectable products may be contaminated

Medications intended for injection require appropriate manufacturing, handling, and sterility controls.

The detection of bacteria in the CBS convenience-store sample raises particular concern because injecting contaminated material can introduce microorganisms beneath the skin and potentially cause an infection.

The appearance of a sealed vial or professional-looking packaging cannot independently establish sterility.

3. Patients may receive medication without an adequate evaluation

A medical questionnaire is not necessarily equivalent to a complete clinical assessment.

Before prescribing a weight-management medication, an appropriately licensed healthcare professional should evaluate relevant medical history, current medications, potential contraindications, and whether the treatment is suitable for the patient.

The evaluation and follow-up required depend on the specific medication and the patient’s circumstances.

4. Dosage and administration instructions may be unreliable

Products obtained through unverified sellers may have inaccurate concentrations, unclear labels, or inconsistent instructions.

For an injectable medication, mistakes in concentration or administration can have serious consequences.

Patients should rely on instructions from their licensed prescriber and dispensing pharmacy, rather than dosing advice from social media, online marketplaces, or research-product sellers.

5. Patients may have no reliable source of follow-up care

A legitimate medical treatment process should include a way to ask questions, report side effects, and obtain further medical assessment when needed.

When products are purchased through anonymous or poorly regulated sellers, patients may have difficulty identifying who manufactured the product, where it came from, or whom to contact if something goes wrong.

Does Buying From a Medical Clinic Automatically Make a Drug Safe?

No.

A legitimate, appropriately licensed medical provider is an important part of safer healthcare, but a clinic’s name, website, or license alone does not establish that every product it offers is FDA-approved or appropriate for a particular patient.

The CBS investigation is a useful reminder of that distinction. Some purchases were made through businesses presenting themselves as healthcare-related providers, yet the reported purchasing process did not include the expected consultation.

Patients should verify both the provider and the medication.

Questions worth asking include:

• Who is the licensed clinician responsible for my evaluation and prescription?

• Is this exact medication FDA-approved, compounded, or investigational?

• Which state-licensed pharmacy will dispense the medication?

• What follow-up and monitoring are appropriate for my treatment?

• Who should I contact if I experience a reaction or have questions?

A credible provider should be willing to explain these details clearly.

FDA-Approved Medications vs. Compounded and Experimental Products

These categories are not interchangeable.

FDA-approved medications have undergone the agency’s review for safety, effectiveness, and quality for their approved uses.

Compounded medications are prepared for particular patient needs under applicable legal conditions. Compounded drugs are not FDA-approved, and the FDA does not review their safety, effectiveness, or quality before marketing. In certain circumstances, an appropriately prescribed compounded medication may address a medical need that an FDA-approved product cannot meet.

Investigational medications, such as retatrutide at the time of the CBS investigation, are still being evaluated. They should not be treated as interchangeable with approved medications simply because they belong to a related drug category.

The FDA specifically states that retatrutide cannot legally be used in compounding.

Patients considering weight-management treatment should discuss the status, potential benefits, limitations, and risks of any proposed medication with a qualified healthcare professional.

How to Check Whether a Medical Provider or Pharmacy Is Legitimate

If you’re seeking weight-management care in Miami or elsewhere in Florida, several practical checks can help.

Verify the healthcare professional

Confirm that the professional responsible for your treatment holds an appropriate, active license. Florida’s Department of Health provides public licensing resources for healthcare practitioners.

You should also understand who will evaluate you and how follow-up care is provided.

Verify the pharmacy

The FDA recommends purchasing prescription medications from properly state-licensed pharmacies.

Its BeSafeRx resources help consumers identify warning signs of unsafe online pharmacies and find state pharmacy license information.

A legitimate online pharmacy should require a valid prescription, have a U.S. address and telephone number, and provide access to a licensed pharmacist.

Check the FDA BeSafeRx guidance

Ask about the exact medication being prescribed

Do not rely only on a broad description such as “weight-loss peptide” or “GLP-1 injection.”

Ask for the exact product name, its FDA approval or compounding status, the dispensing pharmacy’s identity, and the instructions that apply to your prescription.

Be cautious of red flags

Warning signs include websites offering prescription-only medication without a prescription, unclear pharmacy information, unrealistic safety claims, unusual packaging, and unusually low prices.

Labels stating “research use only” or “not for human consumption” should not be interpreted as permission to inject a substance.

Why Medical Supervision Matters for Weight-Management Treatment

Medical weight management should begin with an individualized assessment, not simply selecting a drug from an online product list.

Depending on the patient and treatment under consideration, the evaluation may include medical history, weight-related risk factors, existing health conditions, current medications, and relevant laboratory information.

A clinician can help determine whether medication is indicated, which treatment options may be appropriate, and what monitoring is needed.

This process cannot remove every treatment risk. It does provide a more responsible basis for medical decisions than purchasing an unregulated injection without knowing its identity, quality, or suitability.

For people comparing providers in Miami, it’s also worth reading our guide to choosing a TRT clinic in Miami, which discusses evaluating clinical care and medical oversight.